Table 2 Summary of the potential biomarkers in kidney extracts from db/db mice and wildtype mice.

From: Metabonomic analysis of potential biomarkers and drug targets involved in diabetic nephropathy mice

δ1H(ppm)

metabolites

metabolism pathway

wildtype mice

db/db mice

1.342

Lactate

Glycolysis

38.78 ± 0.76

53.27 ± 2.42**

1.919

Acetate

Fatty acids β-oxidation

3.31 ± 0.09

1.93 ± 0.09**

1.206

3-hydroxybutyrate

Ketogenesis

3.39 ± 0.20

1.52 ± 0.05**

3.037

Creatinine

Serinolysis

7.59 ± 0.22

4.50 ± 0.28**

3.204

Choline

Methylamine metabolism

21.12 ± 1.02

14.12 ± 0.87**

3.275

TMAO

Methylamine metabolism

7.52 ± 0.13

9.41 ± 0.28**

3.545

myo-Inositol

Lipid metabolism

27.45 ± 0.26

28.47 ± 0.34*

2.372

Glutamate

Amino acid metabolism

22.23 ± 0.42

12.68 ± 0.64**

3.557

Glycine

Amino acid metabolism

16.05 ± 0.37

8.10 ± 0.52**

6.909

Tyrosine

Amino acid metabolism

0.44 ± 0.01

0.39 ± 0.01*

5.809

Uracil

Pyrimidine metabolism

0.22 ± 0.01

0.16 ± 0.01**

5.92

Uridine

Pyrimidine metabolism

0.88 ± 0.02

0.73 ± 0.04**

5.94

GTP

Purine metabolism

0.55 ± 0.01

0.47 ± 0.01**

  1. Values are expressed as mean ± SE; Keys: TMAO, trimetlylamine oxide; GTP, guanosine triphosphate; *P < 0.05, **P < 0.01 compared with age-matched wildtype mice.